JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB198912

Anti-n-Myc/MYCN antibody

4

(4 Reviews)

|

(6 Publications)

Rabbit Polyclonal N-Myc/MYCN antibody. Suitable for IHC-P and reacts with Human, Mouse, Rat samples. Cited in 6 publications. Immunogen corresponding to Synthetic Peptide within Human MYCN.

View Alternative Names

BHLHE37, NMYC, MYCN, N-myc proto-oncogene protein, Class E basic helix-loop-helix protein 37, bHLHe37

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-n-Myc/MYCN antibody (AB198912)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-n-Myc/MYCN antibody (AB198912)

Immunohistochemical analysis of paraffin-embedded Human brain tissue labeling n-Myc/MYCN with ab198912 at a 1/50 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-n-Myc/MYCN antibody (AB198912)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-n-Myc/MYCN antibody (AB198912)

Immunohistochemical analysis of paraffin-embedded Human thyroid cancer tissue labeling n-Myc/MYCN with ab198912 at a 1/50 dilution.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse, Rat

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human MYCN. The exact immunogen used to generate this antibody is proprietary information.

P04198

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/200", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "1/50 - 1/200", "IHCP-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "1/50 - 1/200", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

N-Myc also known as MYCN is a transcription factor encoded by the MYCN gene. It plays an important role in cell proliferation and differentiation. The n-Myc protein is part of the Myc family of transcription factors including c-Myc and c-Myb. n-Myc has a molecular weight of approximately 64 kDa. This protein expresses predominantly in developing tissues particularly in the brain but its expression is seen in other tissues during embryogenesis as well. This characteristic makes it important in early development and organ formation.
Biological function summary

N-Myc/MYCN functions in gene regulation by binding to E-box sequences in DNA facilitating transcription of genes essential for cellular growth and metabolism. n-Myc often forms a heterodimer with the MAX protein which enhances its DNA-binding capacity and transcriptional activity. This activity influences processes like apoptosis cell differentiation and cell cycle progression. The ncm mouse model a genetically engineered mouse with MYCN overexpression demonstrates the effects of deregulated n-Myc expression.

Pathways

MYCN significantly impacts the p53 signaling pathway and the Wnt signaling pathway. In the p53 signaling pathway n-Myc interacts with p53 and MDM2 regulating cell cycle checkpoints and apoptosis. In the Wnt pathway MYCN interplays with molecules like β-catenin to influence cell division and differentiation. These interactions highlight the role of n-Myc in maintaining cellular homeostasis and response to external signals that affect growth and division.

N-Myc is closely linked to neuroblastoma and medulloblastoma aggressive forms of pediatric cancers. MYCN amplification often indicates a poor prognosis in neuroblastoma playing a role in tumor progression and resistance to therapy. In medulloblastoma overexpression of n-Myc partners with proteins like Aurora A kinase to promote oncogenesis. Targeting these protein interactions offers potential therapeutic strategies for these MYCN-related cancers.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Positively regulates the transcription of MYCNOS in neuroblastoma cells.
See full target information MYCN

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

In vitro models 3:49-63 PubMed39872066

2025

Microfluidic model of the alternative vasculature in neuroblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Aranzazu Villasante,Maria Jose Lopez-Martinez,Gema Quiñonero,Andrea Garcia-Lizarribar,Xiaofeng Peng,Josep Samitier

Discover. Oncology 14:192 PubMed37878133

2023

Necroptosis-related genes are associated with prognostic features of kidney renal clear cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yiduo Wang,Ke-Hao Pan,Ming Chen

Journal of the American Society of Nephrology : JASN 34:809-828 PubMed36724799

2023

Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Seunghyeok Choi,Seon Pyo Hong,Jung Hyun Bae,Sang Heon Suh,Hosung Bae,Kyung Pyo Kang,Hyuek Jong Lee,Gou Young Koh

Blood cancer journal 9:91 PubMed31748534

2019

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases.

Applications

Unspecified application

Species

Unspecified reactive species

Lucia Mundo,Maria Raffaella Ambrosio,Francesco Raimondi,Leonardo Del Porro,Raffaella Guazzo,Virginia Mancini,Massimo Granai,Bruno Jim Rocca,Cristina Lopez,Susanne Bens,Noel Onyango,Joshua Nyagol,Nicholas Abinya,Mohsen Navari,Isaac Ndede,Kirkita Patel,Pier Paolo Piccaluga,Roshanak Bob,Maria Margherita de Santi,Robert B Russell,Stefano Lazzi,Reiner Siebert,Harald Stein,Lorenzo Leoncini

Theranostics 7:4099-4117 PubMed29158813

2017

Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

A Villasante,K Sakaguchi,J Kim,N K Cheung,M Nakayama,H Parsa,T Okano,T Shimizu,G Vunjak-Novakovic

Cell death and differentiation 24:1564-1576 PubMed28574509

2017

MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.

Applications

Unspecified application

Species

Unspecified reactive species

Alberto Delaidelli,Gian Luca Negri,Asad Jan,Brandon Jansonius,Amal El-Naggar,Jonathan K M Lim,Debjit Khan,Htoo Zarni Oo,Christopher J Carnie,Marc Remke,John M Maris,Gabriel Leprivier,Poul H Sorensen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com